You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MCL

Showing 26 - 50 of 788
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, Adult Trial in Netherlands (azacitidine, Venetoclax, Cobicistat)

Not yet recruiting
  • AML, Adult
  • Amersfoort, Netherlands
  • +17 more
Aug 23, 2023

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (TGR-1202, Ibrutinib)

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Mantle Cell Lymphoma
  • Monterey, California
  • +4 more
Aug 29, 2022

Non-Hodgkin's Lymphoma (NHL), Activated B-Cell Type DLBCL (ABC-DLBCL), Mantle Cell Lymphoma (MCL) Trial in Indianapolis, Spokane

Recruiting
  • Non-Hodgkin's Lymphoma (NHL)
  • +4 more
  • Indianapolis, Indiana
  • +1 more
Jul 12, 2022

Mantle Cell Lymphoma, MCL Trial in United States (Tafasitamab, Lenalidomide)

Recruiting
  • Mantle Cell Lymphoma
  • MCL
  • Basking Ridge, New Jersey
  • +6 more
Mar 27, 2023

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Eprenetapopt, Venetoclax)

Withdrawn
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Feb 23, 2022

CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)

Recruiting
  • CLL
  • +9 more
  • TG-1801
  • Ublituximab
  • Fayetteville, Arkansas
  • +4 more
Jan 20, 2023

Mantle Cell Lymphoma Trial in China (ICP-022)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Hefei, Anhui, China
  • +30 more
Jul 5, 2022

Mantle Cell Lymphoma Trial in China (High dose, Low dose)

Not yet recruiting
  • Mantle Cell Lymphoma
  • High dose
  • Low dose
  • Bengbu, Anhui, China
  • +20 more
Jul 28, 2023

Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma Trial in Worldwide (MIK665)

Completed
  • Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma
  • Houston, Texas
  • +7 more
Jul 27, 2021

Acute Myeloid Leukaemia Trial in Australia, France, United States (S 64315 (also referred as MIK665) and venetoclax)

Terminated
  • Acute Myeloid Leukaemia
  • S 64315 (also referred as MIK665) and venetoclax
  • New Haven, Connecticut
  • +6 more
Dec 20, 2022

Acute Myeloid Leukaemia Trial in Worldwide (S 64315 (also referred as MIK665) and azacitidine)

Active, not recruiting
  • Acute Myeloid Leukaemia
  • S 64315 (also referred as MIK665) and azacitidine
  • Houston, Texas
  • +6 more
Dec 16, 2022

Follicular Lymphoma Patients (Phase IB), Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II) Trial in

Active, not recruiting
  • Follicular Lymphoma Patients (Phase IB)
  • Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)
  • Lenalidomide and GA101
  • Antwerpen, Belgium
  • +24 more
Apr 6, 2022

Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL) Trial in Milwaukee (8/12-Day

Recruiting
  • Non Hodgkin Lymphoma (NHL)
  • +6 more
  • 8/12-Day Production of Car-T Cells
  • +2 more
  • Milwaukee, Wisconsin
    Medical College of Wisconsin and Froedtert Hospital
Jul 1, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL) Trial in Manchester,

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +7 more
  • Manchester, United Kingdom
  • +2 more
Aug 11, 2022

Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Tumor (SM-AHN), Mast Cell Leukemia (MCL) Trial in

Recruiting
  • Advanced Systemic Mastocytosis (AdvSM)
  • +3 more
  • CGT9486 tablets
  • Duarte, California
  • +10 more
Jul 8, 2022

Lymphoma, Mantle-Cell Trial in Italy (Venetoclax)

Active, not recruiting
  • Lymphoma, Mantle-Cell
  • Alessandria, Italy
  • +34 more
Aug 1, 2022

Mantle Cell Lymphoma Trial in Duarte (Acalabrutinib, Ublituximab, Umbralisib)

Suspended
  • Mantle Cell Lymphoma
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Hodgkin Lymphoma Trial in Belgium, Denmark, Netherlands (gemcitabine, cisplatin and tislelizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • gemcitabine, cisplatin and tislelizumab
  • Brussels, Belgium
  • +14 more
Aug 12, 2022

CLL/SLL, NHL, MCL Trial in United States (HMPL-760)

Recruiting
  • CLL/SLL
  • +8 more
  • Atlanta, Georgia
  • +3 more
Feb 24, 2022

Mantle Cell Lymphoma Trial in Hackensack (Lenalidomide, Ibrutinib, Rituximab)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Hackensack, New Jersey
    The Cancer Center at Hackensack University Medical Center
May 3, 2022

CLL/SLL Trial in Worldwide (Epcoritamab, Venetoclax)

Not yet recruiting
  • CLL/SLL
  • Antwerpen, Belgium
  • +23 more
Mar 28, 2023

MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Columbus (drug, biological,

Active, not recruiting
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +9 more
  • BTK inhibitor PCI-32765
  • +5 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 27, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Leukemia (SLL) Trial in United States (Zanubrutinib, Obinutuzumab,

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Leukemia (SLL)
  • Evanston, Illinois
  • +7 more
Sep 9, 2022

Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Duarte (Acalabrutinib,

Recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Acalabrutinib
  • CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Jun 16, 2022

Mantle Cell Lymphoma (MCL) Trial in Japan (Ibrutinib, Venetoclax)

Active, not recruiting
  • Mantle Cell Lymphoma (MCL)
  • Nagoya-shi, Aichi, Japan
  • +11 more
Apr 4, 2022